ArticleJournal of translational medicine2025
Multi-omics analysis reveals the association between intratumoral bacteria and somatic mutational signatures in oral squamous cell carcinoma.
Article in Journal of translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- IntratumoralJournal for immunotherapy of cancer · 2026Article
- Comprehensive analysis and validation of the prognostic value of glycosylation- and mitophagy-related genes for head and neck squamous cell carcinoma.Translational cancer research · 2026Article
- Host-microbiome-immune disequilibrium in oral disease: mechanisms, dysbiosis, and precision therapeutics.Frontiers in immunology · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundOral squamous cell carcinoma (OSCC) poses significant challenges with its obscure etiology and poor prognosis. Intratumoral bacteria exert a significant influence on the progression of OSCC. Nonetheless, the precise composition and role of the intratumoral bacteria in OSCC patients remain obscure and the association between the intratumoral bacteria and somatic mutational signatures in OSCC patients has not been defined.
methodsParaffin-embedded tumors and adjacent normal tissues were collected retrospectively from OSCC patients. A five-region 16S rRNA gene sequencing (5R 16S rRNA-seq) approach (targeting V2, V3, V5, V6, and V8) was employed to characterize the intratumoral bacterial composition of OSCC patients, while whole-exome sequencing (WES) was utilized to identify the somatic mutational signatures of OSCC patients. Then, the multi-omics data were integrated to uncover the association between intratumoral bacterial composition and somatic mutational signatures in OSCC patients. Key findings were validated using fluorescence in situ hybridization (FISH) on tissue microarrays.
resultsWe found significant differences in bacterial profiles between tumors and adjacent normal tissues. The diversity of the bacteria was less within tumor tissues and anaerobic bacteria and periodontopathogens (e.g., Dialister pneumosintes and Prevotella intermedia) were more prevalent in tumor tissues. And the presence of Dialister pneumosintes within tumor tissues is associated with poorer short-term disease-free survival in OSCC patients. The integrated analysis of the 5R 16S rRNA-seq and WES data revealed that tumor mutation burden was positively correlated with the α diversity of the intratumoral bacteria in OSCC patients.
conclusionThis study utilized a multi-omics approach to elucidate the characteristics of the intratumoral bacteria and somatic mutational signatures in OSCC patients, revealing the intricate relationships between these elements. These findings pave the way for hypothesis-driven research aiming to further elucidate the role of the intratumoral bacteria in OSCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.